Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;70(3):408-413.
doi: 10.1007/s12026-022-09272-1. Epub 2022 Mar 3.

Peripheral neuropathies during the COVID-19 pandemic: is there a relation?

Affiliations

Peripheral neuropathies during the COVID-19 pandemic: is there a relation?

Milena Trentinaglia et al. Immunol Res. 2022 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

S. Ferrari received support for attending scientific meetings by Shire, Sanofi Genzyme and Euroimmun. S. Mariotto received support for attending scientific meetings by Merck and Euroimmun and received speaker honoraria from Biogen. The other authors report no competing interests.

References

    1. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurol. 2020;77:683–690. doi: 10.1001/jamaneurol.2020.1127. - DOI - PMC - PubMed
    1. Finsterer J, Scorza FA, Fiorini AC. SARS-CoV-2-associated Guillain-Barre syndrome in 62 patients. Eur J Neurol. 2021;28:e10–e12. doi: 10.1111/ene.14544. - DOI - PMC - PubMed
    1. Jacobs BC, Rothbarth PH, van der Meché FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51:1110–1115. doi: 10.1212/wnl.51.4.1110. - DOI - PubMed
    1. Keddie S, Pakpoor J, Mousele C, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. 2021;144:682–693. doi: 10.1093/brain/awaa433. - DOI - PMC - PubMed
    1. Fragiel M, Miró Ò, Llorens P, et al. Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19. Ann Neurol. 2021;89:598–603. doi: 10.1002/ana.25987. - DOI - PubMed